InsiderTrades.com logo
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

ASCI Insider Trading

Insider Ownership Percentage: 0.77%
Insider Buying (Last 12 Months): £330.22
Insider Selling (Last 12 Months): GBX 0

abrdn Smaller Companies Insider Trading History Chart

This chart shows the insider buying and selling history at abrdn Smaller Companies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

abrdn Smaller Companies Share Price & Price History

Current Price: GBX 238
Price Change: +0.30 (1.20%)
As of 12/7/2023 01:00 AM ET

This chart shows the closing price history over time for ASCI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

abrdn Smaller Companies Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/30/2023David FletcherInsiderBuy140GBX 234£327.60
8/22/2023David FletcherInsiderBuy1GBX 262GBX 262
6/18/2021Christopher MetcalfeInsiderBuy10,000GBX 353£35,300
See Full Table
Trading Experts Call It “The Perfect Tesla Trade”
From Wealthpress   |   Ad
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Click here for details,

SEC Filings (Institutional Ownership Changes) for abrdn Smaller Companies (LON:ASCI)

18.90% of abrdn Smaller Companies stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Aberdeen Smaller Companies Income Trust PLC is a closed ended balanced mutual fund launched by Aberdeen Fund Managers Limited. The fund is managed by Aberdeen Asset Managers Limited. It invests in the public equity and fixed income markets of the United Kingdom. The fund seeks to invest in securities of companies operating across diversified sectors. It primarily invests in stocks of small cap companies, as well as in fixed income securities issued by a variety of issuers. The fund employs fundamental analysis with both top-down and bottom-up security selection approaches to create its portfolio. It benchmarks the performance of its portfolio against the FTSE SmallCap Index - excluding Investment Companies. The fund was formerly known as Aberdeen Smaller Companies High Income Trust PLC. Aberdeen Smaller Companies Income Trust PLC was formed in 1992 and is domiciled in the United Kingdom.
Read More on abrdn Smaller Companies

Today's Range

Now: GBX 238
Low: 238
High: 238

50 Day Range

MA: GBX 238.74
Low: 226.25
High: 259

52 Week Range

Now: GBX 238
Low: 218
High: 289

Volume

N/A

Average Volume

21,197 shs

Market Capitalization

£52.62 million

P/E Ratio

N/A

Dividend Yield

4.02%

Beta

0.96

Who are the company insiders with the largest holdings of abrdn Smaller Companies?

abrdn Smaller Companies' top insider investors include:
  1. David Fletcher (Insider)
Learn More about top insider investors at abrdn Smaller Companies.
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.